Head of Firmware
Bioliberty
Bioliberty develops soft robotic and gamified rehabilitation technology designed to help clinicians deliver high-repetition therapy for patients recovering from stroke and other neurological conditions. The Lifehub system, featuring the Lifeglov soft robotic glove, automatically captures therapy data to support clinical documentation and informed decision-making. The technology is currently used by 26 post-acute care organizations and has treated over 1,465 patients.
- Healthcare Technology
- Robotics
- Medical Devices
- Hardware
- Artificial Intelligence
- Biotechnology
- Digital Health
Updated 2 days ago
Funding
Raised to date
$16.4MRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
across 4 rounds
ABVCC+5$3.3M · Series A Extension
Announced Nov 2026
Disclosed cumulative: $16.4M
4/4
RoundDateAmountValuationInvestors
Founders
Product
Problem
Healthcare facilities face increasing pressure to provide effective physical and occupational therapy due to rising costs, staffing shortages, and a growing number of patients with mobility issues, such as those caused by stroke. Traditional therapy methods can be time-consuming and may not always provide the high-intensity, personalized care needed for optimal patient recovery.
Solution
Bioliberty's Lifehub Clinic system offers an integrated solution that combines soft robotics, gamified therapy, and AI-driven insights to enhance patient outcomes and improve therapy efficiency. The Lifehub system features a central control unit with an interactive therapy interface that powers Bioliberty's soft robotic wearables, such as the Lifeglov, to support patient movement and strength training. The Lifeglov assists with hand extension through controlled, assisted movement, enabling high-repetition therapy sessions. Data captured by Lifehub is centralized in the Lifemind interface, providing clinicians with objective data to track patient progress and make informed treatment decisions.
Target Audience
The primary target audience includes physical and occupational therapists in inpatient and outpatient care settings, as well as healthcare facilities looking to improve patient outcomes and therapy efficiency.
Features
- Lifehub central control unit with an intuitive, user-centric design for quick therapy setup
- Lifeglov soft robotic glove engineered to support hand extension with air-powered, controlled movement
- Multiple therapy modes ranging from active to passively assisted movement to support patients across a range of functional abilities
- Gamified activities to keep patients engaged and motivated during therapy sessions
- Lifemind clinician-facing interface that centralizes therapy data and provides objective insights into patient progress
- Portable and lightweight design for easy transport and storage within clinical settings
- Adaptive AI that continuously learns from patient progress to personalize and fine-tune assistance in real time (future development)